IIOT-OXYS, Inc. CEO and COO Renew Contracts Ensuring Long-Term Stability and Growth
CAMBRIDGE, MA / ACCESSWIRE / June 9, 2022 / IIOT-OXYS, Inc. (OTC PINK:ITOX) announced its CEO, Cliff Emmons, and COO,...
Day: June 9, 2022
Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications
Drug Discovery Collaboration Will Leverage the Botanical Drug Development Expertise of Both CompaniesSAN FRANCISCO, CA / ACCESSWIRE / June 9,...
Aptevo Therapeutics Announces New Preliminary Remission Data on Four Additional Patients Enrolled in On-going APVO436 Dose Expansion Phase 1b Trial for the Treatment of Acute Myeloid Leukemia
Cohort 1 Combination Therapy Arm Shows 36% Remission Rate Among Response-evaluable Patients Treated to DateCohort 3 Monotherapy Patient Achieved Bone...
ORHub Retains Predica to Launch New Software Platform
"ORHub to launch new FutureORTM application in Q3 2022"IRVINE, CA / ACCESSWIRE / June 9, 2022 / ORHub, Inc. (OTC...
Sonnet BioTherapeutics Announces Positive Results from a Preclinical Combination Study of SON-1010 with anti-PD1 Checkpoint Inhibition
Tumor volume growth inhibition improvements observed with the combination of SON-1010 (IL12-FHAB) and a commercially available anti-PD1 antibodyCombination of SON-1010...
Planet 13 Announces Third Florida Dispensary Located in Ocala
LAS VEGAS, NV / ACCESSWIRE / June 9, 2022 / Planet 13 Holdings Inc. (CSE:PLTH) (OTCQX:PLNHF) ("Planet 13" or the...
Better Choice Reminds Shareholders to Vote on Annual Meeting Proposals Before the Proxy Deadline of June 12, 2022
NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a...
Morphic to Present at 2022 Jefferies Global Healthcare Conference
WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of...
TransCode Therapeutics to Participate at BIO International Convention
BOSTON, June 09, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and...
Allied Corp Announces US$147,000 Shipment to Brazil for Specialty Cancer Care Hospital
KELOWNA, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
BioNTech to Provide an Update on Manufacturing and Development Plans of mRNA Vaccines in Africa
MAINZ, Germany, June 9, 2022 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) will welcome its African partners for the first...
Baylor Scott & White Health and Contessa Announce Partnership to Create New Model of At-Home Care for Patients
Partnership will create a continuum of at-home care that encourages patient choice, reduces costs and improves outcomesDALLAS and NASHVILLE, Tenn.,...
Novan Announces Approximately $15.0 Million Registered Direct Offering Priced At-the-Market
DURHAM, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced it has...
SciSparc’s Board of Directors Provides Strategic Decision
TEL AVIV, Israel, June 09, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on...
Amedisys Releases Inaugural Environmental, Social and Governance (ESG) Report
BATON ROUGE, La., June 09, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Exagen Inc. Expands Coverage with MediNcrease
SAN DIEGO, June 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the...
Cend Therapeutics Announces First Patient Treated in Phase 2b Trial of CEND-1 led by Australasian Gastro-Intestinal Trials Group
SAN DIEGO, June 09, 2022 (GLOBE NEWSWIRE) -- Cend Therapeutics, Inc. (“Cend”) today announced that the first patient has been...
Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders
NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline...
Impel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache Society
Oral Presentation Showcases Early Ability to Predict Responders to Trudhesa New Analysis Suggest Patient-Reported Benefits of Long-Term Use with Trudhesa...
Caladrius Biosciences Announces Merger Partner, Cend Therapeutics, has Treated First Patient in Phase 2b Trial of CEND-1 in Collaboration with Australasian Gastro-Intestinal Cancer Trials Group
BASKING RIDGE, N.J., June 09, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage...